New Report on Utilizing RWE in Drug Development Pipeline Throughout the Globe
A new report by consulting group Roots Analysis has been published. It features insight on RWE (real world evidence) when [...]
New FDA Drug Director Appointment Announced, FDA Commissioner Role Remains Open
Patricia Cavazzoni will serve as director of the US Food & Drug Administration’s CDER (Center for Drug Evaluation and Research). [...]
HEOR Experts Release Recommendations to Spur Volume-to-Value Shift and Improve Healthcare Equity
Researchers at the Leonard Davis Institute of Health Economics at the University of Pennsylvania have released a set of recommendations [...]
Maine Citizens Demand Prescription Drug Pricing Action in Public Hearing; 219,000 Mainers Can’t Afford Medication
Maine recently held a public meeting where Mainers discussed how skyrocketing drug prices lead to extreme financial hardship, pain, and [...]
ICER and Aetion Collaborate to Use RWE in Hereditary Angioedema Pilot Study
ICER recently announced a partnership with Aetion. ICER will use Aetion’s RWE (real world evidence) in revising its assessment on [...]
ISPOR Discusses Publication Considerations for HEOR Researchers
Accurate and high-quality research is important in making scientific advances. The COVID-19 pandemic has highlighted some of the obstacles faced [...]
ISPOR Publishes 2021 Science Strategy, 8 Key HEOR Areas Identified Including RWE and HTA Research
ISPOR has published its Science Strategy as part of its Strategic Plan Update 2024. The purpose of the report is [...]
Upcoming ISPOR Webinar on Leadership Development
An ISPOR webinar will take place on May 26th from 10:00 AM to 10:45 AM EDT. It is part of [...]
Use of Reference Pricing in United States Could Lead to Global Consequences
According to a national poll, Americans think that reducing drug prices is one of the top priorities at the federal [...]
AMCP Partnership Forum Discusses State of Rare Disease Outcomes and Research, Orphan Drugs to Hit $242 Billion by 2024
The AMCP (Academy of Managed Care Pharmacy) held a virtual meeting for healthcare professionals, payers, researchers, and pharma companies in [...]
The Journal of Clinical Pathways Issues Call for Papers
The Journal of Clinical Pathways (JCP) invites you to submit research, quality improvement, and perspectives manuscripts for consideration. Articles detailing [...]
HTA Whitepaper Discusses Resulting Value and Economic Benefits
In a whitepaper by researchers at the USC Schaeffer Center and Aspen Institute Advisory Panel, the authors discuss how an [...]
Application Open for 2021 Lancaster University’s Health Economics and Policy MSc Degree
Lancaster University is taking applications for its online Health Economics at Lancaster (HEAL) program. The two-year program offers blended online [...]
How Will States Tackle Unsupported Price Increases?
ICER’s report on UPIs (Unsupported Price Increases) has led lawmakers to consider legislative measures to restrict the prices of prescription [...]
New Ciox Health and HealthVerity Partnership Utilizes COVID-19 RWD
Ciox Health and HealthVerity will partner to conduct a unique clinical trial using RWD (real world data). One source of [...]
New Book on Pharma Market Access Now Available
A new book by Kasem Akhras, PharmD, is now available on Amazon, both as a physical book and as an [...]
Scientist.com Named Among Top 500 Fastest-Growing Companies in The Americas, Number 12 in Health Category According to The Financial Times
Scientist.com, the parent company of HealthEconomics.Com, has been recognized as number 132 of the top 500 Fastest Growing Companies in [...]
New Webinar on RWE and Clinical Trials Now Available
HealthVerity is offering a new webinar on understanding the value of RWE (real world evidence). In addition to reducing the [...]
ISPOR Article Notes Major Consequences if Reference Pricing is Implemented to Reduce Drug Costs
One solution for rising drug prices in the US is the use of reference pricing, rather than our current system [...]
Whitepaper Discusses How Informatics Platforms Streamline R&D
A new whitepaper discusses how the life sciences industry can improve research and development by using informatics platforms. The whitepaper [...]
Johns Hopkins Surgeon Discusses Soaring Healthcare Costs and Possible Solutions
In a recent podcast, Johns Hopkins surgical oncologist Marty Makary discusses how high costs affect patient care, the choice doctors [...]
Bipartisan Lawmakers Urge Action Over Hospital Pricing Noncompliance
In an effort to reduce healthcare costs, a new ruling mandates that hospitals be transparent about the prices they charge [...]
Bundled Payment Healthcare Program Saves Over $16,000 per Procedure and Leads to 75% Lower Readmission Rate
Carrum Health led a bundled payment program, resulting in substantial savings when it comes to the cost of surgical and [...]
Are They Really Orphans? New Report Highlights Misuse of Orphan Drug Designation Driving High Prices
A study recently published in Health Affairs examines whether or not orphan drugs fit the criteria allowing them special privileges [...]
New ISPOR Good Practices Report Includes Guidelines for Cost Analyses
ISPOR has released a new report on how to conduct systematic reviews with cost and cost-effectiveness outcomes (SRs-CCEOs). Mandrik et [...]